Navigating the Evolving Treatment Landscape in Small Cell Lung Cancer: A Payer Perspective on Pathways, Sequencing, and Coverage

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/sclc-evolving-treatment-landscape. This activity will provide managed care professionals with a practical, evidence-based review of the evolving treatment landscape in extensive-stage small cell lung cancer (ES-SCLC), with a focus on how emerging clinical data can inform coverage policies, oncology pathways, and utilization management strategies. Participants will explore the mechanisms of action, clinical evidence, and NCCN-recommended use of current first-line, maintenance, and subsequent therapy options; evaluate the impact of treatment sequencing and maintenance optimization on patient outcomes; and examine key considerations related to safety monitoring, response assessment, reauthorization criteria, and site-of-care decisions. Through real-world patient cases, listeners will gain insights into balancing clinical value, operational feasibility, and timely patient access in a rapidly changing ES-SCLC treatment environment.